Press Releases
POET Technologies Announces Appointment of Sandeep Kumar as Chief Operating Officer
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Company") (NASDAQ: POET), a leader in highly integrated optical engines and light sources for AI networks, today announced the appointment of Sandeep Kumar as Chief Operating Officer reporting to the Chief Executive Officer. Dr. Kumar's appointment was effective as of Monday, May 11, 2026. Dr. Kumar was also named as an Officer of the Corporation...
Hub Group Files Form 12b-25 and Provides First Quarter 2026 Business Update
OAK BROOK, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) today announced that it has filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission (“SEC”) and will be delayed in filing its Form 10-Q for the quarter ended March 31, 2026.
CAMTEK ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2026
Q1 revenues of $121.7 million; Expects over 25% revenue growth in 2H26 versus 1H26 based on strong order momentum Q2 revenue guidance of $129- 131 million MIGDAL HAEMEK, Israel, May 12, 2026 /PRNewswire/ -- Camtek Ltd. (NASDAQ: CAMT) (TASE: CAMT), today announced its financial results for the first quarter ended March 31, 2026...
PowerBank Advances AI Integration with Dual-Agent Deployment
External IR Agent Has Been Live on PowerBank Website Since April 8, 2026 IntelliScope Internal Business Intelligence Platform Deployed on Sovereign AI Infrastructure; Internal Testing Underway TORONTO, May 12, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) ("PowerBank" or the "Company"), a leader in North American energy infrastructure development and asset ownership, is pleased to share an update on the two artificial intelligence agents developed by Intellistake Technologies Corp. (CSE: ISTK) ("Intellistake") under the previously announced AI software contract. The public-facing AI communications agent — designed to serve investors, analysts, and other market participants — has been live on PowerBank's website since April 8, 2026, providing structured, auditable responses to investor enquiries around the clock...
Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
Oral VK2735 demonstrated early, progressive weight loss from Week 1 through Week 13 without a plateau Dose-dependent weight loss observed across all VK2735 cohorts, with the highest dose achieving a mean reduction of up to 12.2% (26.6 lbs) from baseline at Week 13 Baseline characteristics in the ongoing Phase 3 VANQUISH-1 study of VK2735 in adults with obesity were also presented in a second poster at the conference SAN DIEGO, May 12, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today presented additional data from its Phase 2 VENTURE-Oral Dosing trial evaluating the oral tablet formulation of VK2735 at the European Congress on Obesity (ECO) in Istanbul, Türkiye. VK2735 is a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, in development with subcutaneous and oral formulations for the potential treatment of various metabolic disorders...
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
– First-ever FDA approved PROTAC supports the further development and potential of Arvinas' pipeline – – Announced FDA Approval of VEPPANU ™ (vepdegestrant) for the treatment of ESR1m, ER+/HER2- advanced breast cancer – – Announced selection of Rigel Pharmaceuticals for the exclusive global rights to VEPPANU – – Presented ARV-102 (LRRK2 degrader) Phase 1 clinical data in patients with Parkinson's disease demonstrating reduction in endolysosomal and neuroinflammatory biomarkers implicated in Parkinson's disease and progressive supranuclear palsy – – Presented ARV-6723 (HPK1 degrader) preclinical data at the American Associated of Cancer Research Annual meeting demonstrating the potential to overcome immune checkpoint inhibitor resistance in solid tumors – – Initiated dosing with ARV-027 (polyQ-AR degrader) in Phase 1 healthy volunteer trial with single-ascending dose data anticipated in 2H26 – – Company to host conference call today at 8:00 a.m. ET – NEW HAVEN, Conn...
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth
CARMEL, Ind., May 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter period ended March 31, 2026...
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
MOUNTAIN VIEW, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2026, and provided a business update...
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of Commercial and Vice President of Sales, reuniting the team behind the launch of Ohtuvayre, one of the most successful specialty pharmaceutical launches in recent industry history Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of Commercial and Vice President of Sales, reuniting the team behind the launch of Ohtuvayre, one of the most successful specialty pharmaceutical launches in recent industry history
Faraday Copper Intersects Near-Surface Copper Mineralization at Globe, Copper Giant and Marsha Breccias
VANCOUVER, BC / ACCESS Newswire / May 12, 2026 / Faraday Copper Corp. (" Faraday " or the " Company ") (TSX:FDY)(OTCQX:CPPKF) is pleased to announce the results of 19 drill holes from its Phase IV drill program at the Copper Creek Project, located in Arizona ("Copper Creek"). These holes targeted near-surface copper mineralization and addressed infill drilling and geotechnical objectives...
1911 Gold Confirms Extensions of the L10 Zone at True North Intersecting 11.54 g/t Gold over 3.70 m
VANCOUVER, BC, May 12, 2026 /PRNewswire/ - 1911 Gold Corporation ("1911 Gold" or the "Company") (TSXV: AUMB) (OTCQX: AUMBF) (FRA: 2KY) is pleased to provide assay results from the underground resource expansion drill program at the Company's wholly-owned operational and fully permitted True North Gold Project ("True North"), located in southeast Manitoba, Canada. The latest assay results represent twelve (12) drill holes for 3,608 metres ("m") from the underground resource expansion drill program on the L10 Zone ("L10"), in an area located adjacent to Level 16 (720 m below surface, updated as per the recent survey data), one of the main levels of the True North Mine...
CorVel Corporation to Host Live Earnings Release Webcast
FORT WORTH, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly and fiscal earnings results on Wednesday, May 20, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer...
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
STATEN ISLAND, N.Y., May 12, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the first quarter ended March 31, 2026...
Workforce Edge Partners with Southern New Hampshire University to Create New Pathways to Career Advancement for Working Adults
HERNDON, Va.--(BUSINESS WIRE)--Workforce Edge announced its partnership with Southern New Hampshire University (SNHU).
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera (PV) and myelofibrosis (MF)
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
Dosed first participant with OV4071, the first-ever oral potassium-chloride cotransporter 2 (KCC2) direct activator, in May 2026 in a Phase 1 study with healthy volunteers OV329 showed favorable safety, tolerability, pharmacokinetics (PK), and drug exposure at higher doses, supporting the planned advancement of Phase 2 and proof-of-concept studies Announced development expansion of OV329 into additional pediatric indications of tuberous sclerosis complex (TSC) seizures and infantile spasms (IS), conditions for which GABA-aminotransferase (GABA-AT) inhibition is a validated mechanism Strengthened balance sheet, raising $60.0 million of gross proceeds in March 2026 PIPE financing with participation from leading healthcare investors Received $53.9 million in gross proceeds upon full exercise of Series A warrants in connection with October 2025 PIPE financing Cash, cash equivalents and marketable securities were $165.6 million as of March 31, 2026, which does not include $27.3 million in proceeds received in April 2026 from exercise of Series A warrants NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today provided business updates including financial results for the first quarter ended March 31, 2026. “Our first quarter reflected focused execution and continued progress across our pipeline of potentially transformative small molecule medicines for intractable brain conditions,” stated Meg Alexander, President and Chief Executive Officer...
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
– Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in development, regulatory, and commercial milestones and tiered royalites on net sales – NEW HAVEN, Conn., May 12, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, and Pfizer Inc. (NYSE: PFE) have entered into a license agreement with Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and cancer, for the exclusive global development, manufacturing, and commercialization rights for VEPPANU™ (vepdegestrant)...
SOLV Energy Reports First Quarter 2026 Results
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the first quarter ended March 31, 2026. Financial Summary (in $ millions except percentages) Three Months Ended March 31, 2026 2025 Revenue 677 408 Gross Profit 119 59 Gross Margin 17.6% 14.5% Net Loss 1 (27) (1) Adjusted Gross Profit 2 124 59 Adjusted Gross Margin 2 18.4% 14.5% Adjusted EBITDA 93 34 1) Represents Net Loss before Non-Controlling Interest 2) Adjusted Gross Profit and Adjusted Gross Margin exclude the impact of the allocation of non-cash compensation expense to cost of revenue First Quarter 2026 Financial and Recent Business Highlights Revenue of $677 million, up 66% year over year Gross Profit of $119 million, up 102% year over year Adjusted Gross Profit of $124 million, up 110% year over year Net loss of $(27) million Primarily a result of a one-time, non-cash expense of $521 million related to the modification of legacy equity awards from the reorganization in the IPO Adjusted EBITDA of $93 million, up 174% year over year Total backlog as of March 31, 2026 at $8.2 billion Nearly 22 GW under contract for O&M services Announced the acquisition of Roberson Waite Electric (“RWE”) providing the Company additional capabilities and growth opportunities in the utility services market 1) Included in total non-cash compensation expense in cost of revenue and SG&A of approx...
Bitdeer Announces April 2026 Production and Operations Update
Monthly Highlights Bitcoin: Production increased 372% Y/Y to 783 Bitcoin SEALMINERs: SEALMINER A4 series mass production launched with industry leading efficiency of 9.45 J/T Colocation: Executing on colocation lease agreements is THE top priority for management, with Tydal, Norway site in advanced stages of negotiations AI Cloud: Demonstrating strong M/M performance in ARR and utilization rates Key Metrics Summary GlobalEnergyCapacity Self-Mining Hash Rate 1 Co-MiningHash Rate 2 Self-Owned Rigs BTCMined AI CloudARR Colocation AI Data Center 3.0 GW 65.5 (EH/s) 8.4 (EH/s) 218K 783 ~$69M Tydal, Norway in advanced stages of negotiations SINGAPORE, May 12, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced its unaudited operations updates for April 2026. Management Commentary "April marked another month of disciplined execution across our integrated AI and Bitcoin mining platform...
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
On track to report topline data from Phase 3 LEVEL study of TNX-103 in third quarter of 2026 Global Phase 3 LEVEL-2 clinical trial ongoing, enrollment completion anticipated by end of 2027 Strengthened leadership team with appointments of Thomas Staab as Chief Financial Officer and Timothy Healey, MBA, as Chief Commercial Officer CHAPEL HILL, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, reported today financial results for the quarter ended March 31, 2026 and provided an update on its recent corporate progress...
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May
WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in the H.C.
Legend Biotech Reports First Quarter 2026 Results and Recent Highlights
CARVYKTI (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 62% versus first quarter of 2025 to approximately $597 million CARVYKTI now available across 18 global markets, following recent launches in Italy, Poland, the Czech Republic, and Australia Advanced early-stage cell therapy portfolio, with multiple data presentations expected at medical conferences in 2026 Cash and cash equivalents, and time deposits of $834.6 million, as of March 31, 2026 . SOMERSET, N.J...
OTC Markets Group Welcomes Silver X Mining Corp. to OTCQX
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Silver X Mining Corp. (TSX-V: AGX; OTCQX: AGXPF) (or “Silver X”), a rapidly growing silver producer-developer, has qualified to trade on the OTCQX Best Market. Silver X Mining Corp. upgraded to OTCQX from the OTCQB Venture Market...
Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz
ALMATY, Kazakhstan, May 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of JSC Kaspi.kz (Nasdaq: KSPI) hereby announces the Extraordinary General Meeting of Shareholders of JSC Kaspi.kz will be held on 11 June 2026 at 10:00 Astana time at: 154 “А”, Nauryzbai Batyr Street, Almaty, Kazakhstan, 050013. If a quorum is not met, a repeated General Meeting of Shareholders will be held on 12 June 2026 at 10:00 Astana time at: 154 “А”, Nauryzbai Batyr Street, Almaty, Kazakhstan, 050013...
AAR hosts 2026 Investor Day and provides updates on long-term strategy and three-year financial framework
WOOD DALE, Ill., May 12, 2026 /PRNewswire/ -- AAR CORP.
Xylem Releases 2025 Sustainability Report
WASHINGTON--(BUSINESS WIRE)-- #LetsSolveWater--As global water challenges intensify, efficient and resilient water management is more critical than ever. Xylem (NYSE: XYL), a leader in global water solutions, has released its 2025 Sustainability Report, demonstrating how customer-driven innovation is transforming sustainability commitments into measurable performance outcomes for communities and the environment. Performance Highlights 20 million people reached with access to clean water, sanitation, and hygiene...
MRI-Simmons Launches Streaming + Local Study to Unlock Deeper Consumer Insights Across 205 U.S. Markets
NEW YORK--(BUSINESS WIRE)--In a step forward for local media planning, MRI-Simmons has launched a new Streaming + Local Study, offering advertisers comprehensive insights into evolving media habits and other consumer behaviors across 205 local U.S. markets. The Streaming + Local Study combines insights from two core MRI-Simmons studies; Cord Evolution and Local Flex. Cord Evolution examines why and how viewers shift from traditional TV to streaming platforms, and tracks viewing behaviors across...
Brera Holdings PLC (d/b/a Solmate Infrastructure) Announces Reverse Share Split to Regain Compliance with Nasdaq's Minimum Bid Price Rule
DUBLIN--(BUSINESS WIRE)--Brera Holdings PLC, operating under the name Solmate Infrastructure (the “Company”) (NASDAQ: SLMT) today announced a 1-for-10 reverse share split (the “Reverse Share Split”) of the Company's ordinary shares. The Company's board of directors approved the Reverse Share Split on May 1, 2026, and the Company obtained shareholder approval for the Reverse Share Split at an extraordinary general meeting on April 7, 2026. The Company's Class B ordinary shares will continue to t...
Glaukos Announces Participation in Upcoming Investor Conferences
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences: Stifel Virtual Ophthalmology Forum on Tuesday, May 26, 2026, at 1:30 p.m. ET William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026, at...
Ralliant Reports First Quarter 2026 Results and Raises Full Year Guidance
RALEIGH, N.C.--(BUSINESS WIRE)--Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) today announced financial results for the first quarter of 2026. For the first quarter, revenue of $535 million was up 11% year-over-year and up 9% organically year-over-year. Net earnings were $44 million, and adjusted net earnings were $65 million, resulting in EPS of $0.39 and adjusted EPS of $0.57. Net earnings margin was 8.3%, a 500 basis point decline year-over-year. Adjusted EBITDA margin was 1...
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
WATERTOWN, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today reported financial results for the first quarter ended March 31, 2026, as well as recent business highlights...
Loblaw Releases 2025 Live Life Well® Report Highlighting Progress in Sustainability, Community Support, and Social Impact
BRAMPTON, Ontario, May 12, 2026 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (TSX: L) released its 2025 Live Life Well report, highlighting the Company's continued progress across environmental, social, and governance (ESG) priorities.
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
FREDERICK, Md., May 12, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 19, 2026, at 3:00 p.m. ET...
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
NEO-CYT marks the first evaluation of MDNA11 in earlier-stage cancers, as a potentially curative treatment; extends development beyond the heavily pretreated metastatic setting of the ongoing Phase 1/2 ABILITY-1 study
George Weston Limited Reports First Quarter 2026 Results
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- George Weston Limited (TSX: WN) (“GWL” or the “Company”) today announced its consolidated unaudited results for the 12 weeks ended March 28, 2026(2).
Premier American Uranium Commences Drilling at Cebolleta as Part of 2026 Metallurgical Testing
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. (“PUR” or “Premier American Uranium” or the “Company”) (TSXV: PUR, OTCQB: PAUIF) is pleased to announce that drilling has commenced at its Cebolleta Uranium Project in New Mexico (“Cebolleta” or the “Project”), marking an important step in the Company's 2026 work program focused on advancing metallurgical optimization and project economics...
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
NEWTON, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD), today reported financial results for the first quarter of 2026 and provided a business update...
eToro Reports First Quarter 2026 Results
Net Contribution of $258 million, up 19% YoY Net Income of $82 Million, up 37% YoY Adjusted EBITDA of $109 million, up 35% YoY 4.02 million funded accounts, up 12% YoY NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced financial results for the first quarter ended March 31, 2026...
Canterra Minerals Completes Winter Drilling and Commences Geophysical Survey at Critical Minerals and Gold Projects in Central Newfoundland
VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Canterra Minerals Corporation (TSXV: CTM) (OTCQB: CTMCF) (FSE: DXZB) (“Canterra” or the “Company”) continues to advance its critical and precious metals projects in Central Newfoundland. Winter diamond drilling of 8 holes totalling 2,386 metres was completed at its Buchans project, with assay results anticipated in Q2 2026...
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM Co-founder and CEO, Dr Andrea Pfeifer, to retire after a distinguished 23-year tenure Board Chair, Martin Zügel, MD, to be appointed interim CEO Dr Pfeifer to serve as an Advisor and Honorary Chair of the Board of Directors, and Co-Chair of the Scientific Advisory Board Company well-positioned to drive short- and long-term value creation via its wholly-owned pipeline and strategic partnerships Robust balance sheet following recently achieved milestones, with multiple further near-term value-inflection milestones Lausanne, Switzerland, 12 May 2026 -- AC Immune SA (Nasdaq: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announces that Dr Andrea Pfeifer has decided to retire from her role as Chief Executive Officer (CEO) of AC Immune at the upcoming Annual General Meeting (AGM) to spend more time with her family. AC Immune's Board of Directors has appointed the Chair, Dr Martin Zügel, to serve as interim CEO while the ongoing search for a permanent successor continues...
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
PATCHOGUE, N.Y., May 12, 2026 (GLOBE NEWSWIRE) -- Blue Point Brewing, a Long Island craft brewery and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is launching a new year-round offering, Magic Hour IPA.
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
Closed Private Placement of Up to $354 Million, Including $180 Million Upfront and $174 Million in Milestone-Driven Warrants Appoints New CEO and Expands Board of Directors Advances U . S . -based Manufacturing Transition & Partnership Conference Call Scheduled for 8:30 AM EDT Today, May 12, 2026 SEATTLE and VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced financial results for the first quarter of 2026 and provided corporate highlights, including the recent financing and leadership updates...
Broadwind Announces First Quarter 2026 Results
CICERO, Illinois, May 12, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the first quarter 2026. FIRST QUARTER 2026 RESULTS (As compared to the first quarter 2025) Total revenue of $34.1 million GAAP net loss of ($0.5) million, or ($0.02) per diluted share Non-GAAP Adjusted EBITDA of $2.2 million, or 6.5% of total revenue* Total orders of $37.4 million, +23% y/y Ratio of net debt to trailing twelve-month non-GAAP adjusted EBITDA of 1.7x as of March 31, 2026 *For a reconciliation of GAAP to non-GAAP metrics, please see the appendix of this release MANAGEMENT COMMENTARY “During the first quarter, we continued to advance our business transformation strategy, while delivering strong revenue growth, margin realization, and order growth in our core gearing and industrial solutions segments,” stated Eric Blashford, President and CEO of Broadwind...
Sionna Therapeutics Reports First Quarter 2026 Financial Results
Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track for the summer of 2026 Ongoing Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers is also on track for topline data in the summer of 2026 Maintained strong cash position with approximately $289.9 million in cash and cash equivalents, expected to fund operations into 2028 WALTHAM, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) today reported financial results for the first quarter ended March 31, 2026, and provided a business update...
ProQR Announces First Quarter 2026 Operating and Financial Results
AX-0810 target engagement data in healthy volunteers on track for Q2 2026; biliary atresia selected as initial Phase 2 indication Pipeline expansion with advancement of AX-0811 (NTCP) and AX-0422 (IDUA) toward the clinic, supporting multiple upcoming clinical catalysts Continued advancement of Axiomer platform, including AI-enabled discovery capabilities, partnership with Ginkgo Bioworks, and formation of AI Advisory Board Ended Q1 2026 with € 81.1 million cash and cash equivalents, supporting runway into mid-2027 LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V...
Creative Realities, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
LOUISVILLE, Ky., May 12, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, announced today that it will release its financial results for the three months ended March 31, 2026 before the market opens on Friday, May 15, 2026...
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
ROCKVILLE, Md., May 12, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company), a global biotechnology platform company committed to accelerating access to innovative medicines that address significant unmet needs, today announced that members of NovaBridge's management team will participate in the upcoming H.C...
Sirios Adds $3.5 Million to Its Cash Reserves Following the Exercise of Warrants and Stock Options
Montreal, Quebec--(Newsfile Corp. - May 12, 2026) - Sirios Resources Inc. (TSXV: SOI) (OTCQB: SIREF) ("Sirios" or "the Company") announces an additional capital injection, which provides it with greater financial flexibility to carry out its exploration and investment programs. Since the update on January 15, 2026, the exercise of 28,439,748 warrants and 2,100,000 options has added $3,472,730 to Sirios's cash balance and resulted in the issuance of 30,539,748 shares...
Omai Gold Intersects 3.86 g/t Au over 23.8m and 3.49 g/t Au over 16.9m at Wenot and Plans Drill Hole to Test Depth Potential of Gilt Deposit
Toronto, Ontario--(Newsfile Corp. - May 12, 2026) - Omai Gold Mines Corp. (TSXV: OMG) (OTCQB: OMGGF) ("Omai Gold" or the "Company") is pleased to announce assay results from seven additional drill holes from the current drill program at its 100% owned Omai Gold Project in Guyana, South America. Three of the seven holes were collared in Central Wenot, two in East Wenot and one at the western end of the Wenot deposit...
The Awareness Group Launches No FICO Solar Plus Battery PPA Program Across Seven High-Demand U.S. and Territorial Markets
Program expands access to solar savings and battery backup for homeowners while providing EPCs and sales organizations with a scalable clean energy financing solution Scottsdale, Arizona--(Newsfile Corp. - May 12, 2026) - The Awareness Group (OTC: TAAG) (TAG), $TAAG, an emerging national player in solar energy services and financing solutions and creator of the TAG GRID, today announced the official launch of its No FICO Solar Plus Battery Power Purchase Agreement (PPA) program across seven priority markets: California, Puerto Rico, the U.S. Virgin Islands, Massachusetts, Connecticut, New Jersey and New York. Pablo Diaz, CEO and Founder of The Awareness Group, commented: "This program dramatically expands who can participate in the clean energy economy while giving our EPC and sales partners a high conversion product in markets where demand is accelerating...
First Majestic Announces Q1 2026 Financial Results and Increased Quarterly Dividend Payment; Provides Management Updates
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - First Majestic Silver Corp. (NYSE: AG) (TSX: AG) (FSE: FMV) (the "Company" or "First Majestic") is pleased to announce the Company's unaudited condensed interim consolidated financial results for the first quarter ended March 31, 2026. The full version of the quarterly financial statements and the accompanying management's discussion and analysis can be viewed on the Company's website at www.firstmajestic.com or under the Company's profiles on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov/edgar...
Brookdale to Present at the Bank of America Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference
BRENTWOOD, Tenn., May 12, 2026 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or "the Company") announced today that Company management is scheduled to participate in two investor conferences in May 2026.
OceanaGold Announces Additional High-Grade Drill Results at Haile
VANCOUVER, BC, May 12, 2026 /PRNewswire/ - OceanaGold Corporation (TSX: OGC) (NYSE: OGC) ("OceanaGold" or the "Company") is pleased to announce high-grade results from its ongoing exploration and resource conversion drilling program at the Haile Gold Mine ("Haile") in the United States. Drilling Highlights (core length): Horseshoe Underground (conversion and extension drilling): 15.5 m @ 30.64 g/t Au (UGD0121) 30.5 m @ 13.86 g/t Au (UGD0113) 22.5 m @ 13.42 g/t Au (UGD0122) 18.4 m @ 9.62 g/t Au (UGD0119) 21.9 m @ 6.48 g/t Au including 3.7 m @ 23.55 g/t Au (UGD0120) 26.3 m @ 3.41 g/t Au and 44.3 m @ 3.72 g/t Au (UGD0107) Ledbetter Underground (conversion drilling): 27.9 m @ 8.60 g/t Au (DDH1313) 27.9 m @ 4.16 g/t Au (DDH1319) 18.4 m @ 3.68 g/t Au (DDH1317) 13.0 m @ 2.25 g/t Au and 17.1 m @ 8.20 g/t Au (DDH1283) 2.6 m @ 9.63 g/t Au and 3.3 m @ 40.45 g/t Au (DDH1315) Clydesdale (initial drilling): 14.5 m @ 15.81 g/t Au including 4.5 m @ 41.6 g/t Au (DDH1305) Gerard Bond, President and CEO of OceanaGold, said "Our ongoing exploration success at Haile continues to demonstrate our ability to add tremendous value through the drill bit...
IsoEnergy Confirms High Grade Uranium Mineralization on the Hurricane South Trend, with up to 4.21% U3O8 over 3.5 m, including up to 11.6% U3O8 over 1.0 m
TORONTO, May 12, 2026 /PRNewswire/ - IsoEnergy Ltd. ("IsoEnergy", or the "Company") (NYSE American: ISOU) (TSX: ISO) is pleased to announce assay results from its recently completed 2026 winter exploration drilling program at the Larocque East project (the "Project"), home to the high-grade Hurricane deposit ("Hurricane" or the "Deposit"), in the eastern Athabasca Basin, Canada...
Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Announces Assay Drill Results up to 13.9% Antimony (Sb) in Stibnite Bearing Core
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - Antimony Resources Corp. (CSE: ATMY) (OTCQB: ATMYF) (FSE: K8J0) (the "Company" or "Antimony Resources" or "ATMY") is pleased to announce that it has begun to receive assay results for the latest phase of drilling at Bald Hill Antimony deposit in New Brunswick, Canada. In addition, drilling has commenced at the Project with a target of approximately 13,000 meters in the area of the Main Zone and 6,000 meters in the new discovered zones...
Defense Metals Commences Pilot Flotation Test Program at SGS Lakefield for the Wicheeda Rare Earth Project
VANCOUVER, BC, May 12, 2026 /PRNewswire/ - Defense Metals Corp. ("Defense Metals" or the "Company"; (TSXV: DEFN) (OTCQB: DFMTF) (FSE:35D), a company focused on the development of its wholly-owned Wicheeda Rare Earth Project (the "Wicheeda Project"), located near Prince George, British Columbia, Canada, is pleased to announce the commencement of a confirmatory pilot flotation plant test program for its Wicheeda Project. The program will be conducted at the SGS Canada Inc. metallurgical facility in Lakefield, Ontario...
Alliance Reports First Quarter 2026 Results
First quarter Net revenues of $427 million, up 10% versus prior year First quarter Net income of $57 million compared to $17 million in the same period of 2025 with Net income margin of 13.3%; Adjusted Net Income of $63 million, up 85% versus prior year First quarter Adjusted EBITDA of $109 million, up 9% versus prior year, with Adjusted EBITDA Margin of 25.5% Repaid $65 million of debt in the quarter and Net Leverage reduced 0.2x to 2.6x Raises low end of full year 2026 guidance: revenue growth now expected at +6% to 7% and Adjusted EBITDA growth at +7% to 8%1 RIPON, Wis., May 12, 2026 /PRNewswire/ -- Alliance Laundry Holdings Inc. (NYSE: ALH) ("Alliance" or the "Company"), the global leader in commercial laundry equipment, today announced results for its first quarter ended March 31, 2026, and raised the low end of its full year 2026 guidance...
Visionary Metals Corp. Adopts Semi-Annual Financial Reporting
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - VISIONARY METALS CORP. (TSXV: VIZ) ("VIZ" or the "Company") is pleased to announce that it has elected to rely on Coordinated Blanket Order 51-933 and move to semi-annual financial reporting ("SAR").
Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer
VEPPANU has a novel mechanism of action, is the first and only FDA-approved PROTAC and has the potential to become an important new treatment option for adult patients with 2L+ ER+/HER2-, ESR1-mutated mBC Pivotal Phase 3 VERITAC-2 clinical trial results showed that vepdegestrant was generally well tolerated and reported mPFS of 5.0 months vs. 2.1 months for fulvestrant, a 2.4-fold improvement, in patients with 2L+ ER+/HER2- mBC with an ESR1 mutation Upon closing of the transaction, VEPPANU will become Rigel's fourth commercial product and its major focus to accelerate revenue growth while leveraging the company's existing infrastructure, contributing meaningfully to the advancement of Rigel's transformational growth strategy Arvinas and Pfizer will receive an upfront $70.0 million and an additional $15.0 million upon the successful completion of certain transition activities, and are eligible for up to $320.0 million in future potential regulatory and commercial milestones Rigel to host a conference call today at 8:00 a.m...
Parex Resources Positioned to Become Colombia's Largest Independent Oil & Gas Producer, Provides Step-Change Guidance, Reports Q1 2026 Results, and Declares Q2 2026 Dividend
CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce that the Company is poised to become Colombia's largest independent oil and gas producer and to provide new corporate guidance. Additionally, the Company reports its financial and operating results for the three-month period ended March 31, 2026, and the declaration of its Q2 2026 regular dividend of C$0.385 per share...
Abaxx Announces First Quarter 2026 Earnings and Business Update Call
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX) (OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that it will host a webcast to discuss its first quarter 2026 financial results and provide an update on the Company's business and market development on Tuesday, May 19th at 10:00 a.m...
Beamr to Demonstrate Video Data Processing for Resilient AV Models at Smart Mobility Summit
Herzliya, Israel, May 12, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced that it will demonstrate its ML-safe video data stack for autonomous vehicles (AV) at Smart Mobility Summit 2026, held from May 17–18 at Expo Tel Aviv...
Creator TV Sports™' Creator Poker Championship to Premiere on CBS Sports Network
Produced series marks the Creator Poker Championship's transition from livestream to television. TORONTO, May 12, 2026 /PRNewswire/ -- Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF) (the "Company" or "Sabio"), a Los Angeles-based ad-tech company helping top global brands reach, engage, and validate (R.E.V...
Climb Bio to Present at Upcoming Investor Conferences
WELLESLEY HILLS, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below...
Veritone Reports First Quarter 2026 Results, Reaffirms 2026 Guide of $130-$145 million in Revenue in Fiscal 2026
IRVINE, Calif.--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI) (“Veritone” or the “Company”), a leader in enterprise AI and data solutions, today announced results for the first quarter ended March 31, 2026. “During the first quarter, we accelerated the commercialization of Veritone Data Refinery, expanded public sector adoption, and further strengthened the foundation of our AI platform,” said Ryan Steelberg, President and Chief Executive Officer of Veritone. “With additional leading hyperscal...
Via Announces First Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Via Transportation, Inc. (NYSE: VIA), the world's leading platform for public transit software and services, today announced financial results for the first quarter of fiscal year 2026, which ended March 31, 2026. "We are delighted with our first quarter results, which reflect the strength of demand for Via's platform and the value we deliver to cities and transit agencies globally," said Daniel Ramot, Via's Co-founder and Chief Executive Officer. "Surpassing $500M in...
Kraft Heinz Celebrates 250 Years of Summer Cookouts with “The United Tastes of America”
CHICAGO--(BUSINESS WIRE)--As America approaches its 250th anniversary, The Kraft Heinz Company is marking the moment the only way it knows how: by bringing people together over food. Today, as part of its America250 sponsorship, the company unveils “The United Tastes of America”, its largest portfolio campaign in history, celebrating the role its iconic brands have played in one of America's favorite pastimes: summer cookouts. Coupled with never-before-seen products hitting grocery store shelve...
Sleep Number Announces First Quarter 2026 Results
MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended April 4, 2026. Linda Findley, President and CEO, commented, “Q1 came in as expected given the soft start to the year, but year-over-year demand improved steadily throughout the quarter, ending with growth in March over last year. We are confident in the early positive metrics we are seeing from our new product launch and marketing campaigns, and the customer feedback on our new bed...
D-Wave Reports First Quarter 2026 Results
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced financial results for its first quarter ended March 31, 2026. “D-Wave's first quarter performance highlights what sets this company apart: strong execution, expanding commercial adoption, and differentiated technology leadership across both annealing and gate mo...
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C.
Colliers to partner with specialist engineering and design firm
Expands aviation, mission critical, and federal expertise across the U.S. Expands aviation, mission critical, and federal expertise across the U.S.
NexGold Initiates VTEM™ and FALCON® Gravity Airborne Geophysical Surveys at Goldboro and Announces Appointment of New Board Member
TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce that it has initiated a 2,496-line kilometre helicopter airborne Versatile Time Domain Electromagnetic Survey Plus (“VTEM TM Plus”) survey and a 2,656-line kilometre FALCON fixed-wing airborne gravity gradiometer survey over its 32,007 hectares (~320 km2) of prospective exploration land at the Goldboro Gold Project (“Goldboro”). The surveys are expected to be completed in the second quarter of 2026 and are intended to support the development of additional exploration targets for follow-up regional exploration programs, as well as to further characterize the Goldboro Gold Deposit and its regional geological controls...
Cal-Maine Foods and Sara Lee Frozen Bakery Announce Cal-Maine Foods' Acquisition of Van's Foods Brand, Advancing Cal-Maine Foods' Diversification Strategy and Expanding Consumer-Facing Retail Presence
Cal-Maine Foods acquires Van's Foods to expand prepared foods, boost B2C retail growth, and strengthen its better-for-you frozen breakfast portfolio.
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
Opus Genetics Virtual R&D Science Forum Scheduled for Tuesday, June 16, 2026, at 10:00 am ET Upcoming Data Readout for Cohort 1 of OPGx-BEST1 Gene Therapy Study Expected in September 2026 LCA5 Accepted to FDA's Rare Disease Evidence Principles (RDEP) Program and Enrolling Pivotal Trial RDH12, MERTK and RHO Programs Expected to Advance to Clinical Testing in the Next 12 Months Cash Runway into 2029 Expected to Support Multiple Clinical Inflection Points, Potential Product Approvals and Opportunities for Priority Review Vouchers RESEARCH TRIANGLE PARK, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update...
Mediacom Advances Its DOCSIS 4.0 Network Upgrades Plans With AOI Quantum Bandwidth
SUGAR LAND, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics Inc. (NASDAQ: AAOI), a leading provider of advanced optical and HFC networking products that power AI, today announced it is working with Mediacom to accelerate the upgrade and continued expansion of its fiber and coax network infrastructure. Mediacom, the fifth largest cable operator in the U.S. offering high-speed data, video, phone, and mobile services to more than three million homes and businesses across 22 states, announced plans last year to upgrade its network to offer faster upload and download speeds to 1 million homes by the end of 2026...
Lantronix xPico 600 Brings Wi-Fi 6, Enterprise Security and Cloud Management to Industrial IoT — All in a Single Embedded Module
IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today introduced the xPico 600 series , a production-ready family of Wi-Fi 6 and Bluetooth Low Energy (BLE) 5.4 embedded gateway modules that solve one of embedded IoT development's biggest challenges: time-to-revenue...
American Battery Materials Provides Operational Update on Lisbon Valley Development Evaluation
American Battery Materials, Inc. provided an operational update regarding ongoing evaluation activities at its Lisbon Valley Project in San Juan County, UT
American Shared Hospital Services Announces First Quarter 2026 Financial Results Conference Call
SAN FRANCISCO, May 12, 2026 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its equipment leasing and direct patient care services segments, today announced that the Company will hold a conference call to discuss its first quarter 2026 financial results on May 14th at 12:00 pm ET. The first quarter 2026 financial results press release will be issued before the market opens on May 14th, 2026...
Yukon Metals Expands Porphyry Portfolio With New Northern BC Property Near Yukon Border
VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company”) is pleased to announce that it has acquired a 100% interest in the KLM Property (the “Property”), located in northern British Columbia near the Yukon border. The Property comprises 8 mineral claim groups covering approximately 11,761 hectares and is situated within a prospective region characterized by extensive intrusive rocks and favourable structural architecture considered conducive to porphyry-style mineralization...
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
This marks the fifth MedTech Breakthrough Award that Castle has earned for its innovative testing solutions FRIENDSWOOD, Texas, May 12, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its AdvanceAD-Tx test has been selected as the winner of the "Genomics Innovation Award" in the 10th annual MedTech Breakthrough Awards program, which recognizes companies driving meaningful progress and improving patient care across the global health and medical technology industry. AdvanceAD-Tx is Castle's clinically validated gene expression profile (GEP) test designed to guide systemic treatment decision making in patients 12 and older with moderate-to-severe atopic dermatitis (AD)...
Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems
Labcorp's full test menu will be available through Epic's Aura platform Integration builds on the successful deployment of Invitae genetic testing and accelerates access to the latest genetic and specialty diagnostics through Aura Collaboration will help reduce IT complexity, streamline lab ordering and improve access to diagnostic innovation for hospitals and health systems using Epic nationwide BURLINGTON, N.C., May 12, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Epic, the nation's leading electronic health record (EHR) supporting hospitals and health systems...
LiveOne (Nasdaq: LVO) Subsidiary PodcastOne (Nasdaq: PODC) Receives $5.5M Cash Payment from $3 Per Share Warrant Exercise
Proceeds to support podcast and podcast network acquisitions, expand LVO's TV Network and Celebrity Brands division, and accelerate AI initiatives across 250,000+ hours of audio and video content LVO and its bankers are actively evaluating strategic alternatives, including potential consolidation of PodcastOne and additional M&A opportunities LVO currently owns ~20.5M shares of PODC common stock LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- LiveOne, Inc. (Nasdaq: LVO) today announced that its subsidiary, PodcastOne, Inc. (Nasdaq: PODC), has received approximately $5.5 million in cash proceeds from the exercise of warrants of PodcastOne common stock at $3 per share. “Receiving this additional capital meaningfully strengthens our balance sheet and positions us to aggressively pursue strategic growth opportunities across podcasting, television, celebrity brands and AI,” said Robert Ellin, Chairman and CEO of LiveOne...
Hyundai Motor Brings Spirit of FIFA World Cup 2026™ to Driver's Seats with New Display Theme
Hyundai Motor launches exclusive FIFA World Cup 2026™ Display Theme for select models in Korea, the United States, Canada and Europe The theme is part of the 'Next Starts Now' campaign, linking the excitement of the FIFA World Cup 2026™ to Hyundai Motor's vision of progress and innovation Features unique animations of Boston Dynamics' Atlas and Spot robots, bringing the robotics vision into the driving experience The free theme underscores the growing importance of software-enabled, customizable in-vehicle experiences for drivers SEOUL, South Korea, May 12, 2026 /PRNewswire/ -- Hyundai Motor Company has today launched an exclusive in-vehicle display theme to celebrate the upcoming FIFA World Cup 2026™. Available in Korea, the United States, Canada and Europe, the theme brings the excitement of the world's biggest football tournament directly into Hyundai vehicle's digital cockpit...
CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
FDA feedback on the Auxora™ pivotal program in acute pancreatitis and potential future development in acute kidney injury expected in 2Q 2026 Preclinical and IND-enabling studies advancing for CM5480, an oral CRAC channel inhibitor candidate, with IND submission in pulmonary hypertension expected in 2027 LA JOLLA, Calif., May 12, 2026 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases, today reported financial results for the first quarter ended March 31, 2026 and provided clinical and corporate updates...
Cloopen Enters into Definitive Merger Agreement for Going-Private Transaction
BEIJING, May 12, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with SpringX Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands ("Parent"), AutumnX Holdings Limited ("HoldCo"), an exempted company incorporated with limited liability under the laws of the Cayman Islands and a wholly-owned subsidiary of Hold C o, p ursuant to which the Company will be owned b y a consortium consisting of Mr. Changxun Sun, the Company's founder and chief executive officer, Cloopen Co., Ltd...
Madison Air Reports First Quarter 2026 Results
Backlog up 115.5% year-over-year and orders up 29.1% on a combined basis*** Net sales of $923.7 million, up 33.8%, including 12.5% on a pro forma basis** Net income of $43.0 million, down 6.9%, adjusted net income* up 32.1% Adjusted EBITDA* of $233.4 million, up 38.7%, with adjusted EBITDA margin* of 25.3%, up 89 bps Cash flow from operations - continuing operations of $57.8 million and free cash flow* of $50.4 million Continued de-leveraging, pre-IPO down ~0.2x from year end, post IPO adjusted net leverage 3.0x *This news release contains non-GAAP financial measures. Definitions and reconciliations of the non-GAAP financial measures can be found under "Selected Financial Data, Non-GAAP Measures and Definitions...
LightInTheBox Reports First Quarter 2026 Financial Results
Revenues Return to Double-Digit Growth Record First-Quarter Profit of $1.2 Million Eighth Consecutive Profitable Quarter SINGAPORE, May 12, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced its unaudited financial results for the first quarter ended March 31, 2026...
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
HOLON, Israel, May 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today announced that management will present at the 2026 Stifel Virtual Targeted Oncology Forum.
Roxmore Resources Reports Significant Drill Results From The Converse Project, Battle Mountain - Eureka Trend Nevada
VANCOUVER, BC / ACCESS Newswire / May 12, 2026 / Roxmore Resources Inc. (TSX:RM)(OTCQX:GARLF) ("Roxmore" or the "Company") is pleased to report gold and silver results from the ongoing drill campaign at its flagship Converse Gold Project ("Converse" or "the Project"). Results include significant intercepts of 138.1m grading 0.65 g/t Au and 3.5 g/t Ag from 57m and 110.9m grading 1.31 g/t Au and 2.84 g/t Ag from 459.6m depth...
Helio Launches High-Impact Bi-Coastal Investor Roadshow, Advancing Strategic Outreach from California to Wall Street
BERKELEY, CA / ACCESS Newswire / May 12, 2026 / Helio Corporation (OTC PINK:HLEO) ("Helio" or the "Company"), a developer of advanced space power and engineering solutions supporting next-generation space infrastructure, today announced a significantly expanded and strategically positioned May 2026 investor roadshow spanning both the West and East Coasts. The initiative reflects growing investor demand, increasing market visibility, and the Company's continued commitment to proactive engagement with the investment community...
ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone.
FORT LAUDERDALE, FL / ACCESS Newswire / May 12, 2026 / ZEO ScientifiX (OTCQB:ZEOX) ("ZEO" or the "Company"), a regenerative medicine products company serving physician-run clinics across the United States, today announced that it had reached a defining commercial milestone. For the first time in Company history, ZEO's single month unaudited sales surpassed the $1 million mark in April 2026...
Irving Resources Receives Positive Assay Results from Omu Sinter and Encounter Feeder Style Mineralization in Recent Drill Holes
VANCOUVER, BC / ACCESS Newswire / May 12, 2026 / Irving Resources Inc. (CSE:IRV)(OTCQX:IRVRF)(FSE:1IR) ("Irving" or the "Company") is pleased to announce receipt of encouraging assay results from the Omu Sinter epithermal gold-silver project located near Omu, Hokkaido, Japan. In addition to these positive results, recent diamond drilling has encountered apparent feeder style hot spring mineralization along the eastern extension of the sinter terrace...
Immatics Announces First Quarter 2026 Financial Results and Business Update
SUPRAME Phase 3 interim and final analysis for PRAME cell therapy, anzu-cel, expected to be triggered in 2026, advancing toward the Company's first commercial launch planned in 2027 Multiple key clinical data sets expected in 2026 across the portfolio, including four clinical-stage cell therapy and bispecific candidates targeting cutaneous and uveal melanoma, gynecologic cancers (ovarian and uterine), head and neck cancer, and other solid tumor indications Phase 1 data readout with second-generation PRAME cell therapy, IMA203CD8, to be presented at the 2026 ASCO meeting, focusing on anti-tumor activity in gynecologic cancers Phase 1b clinical data from PRAME bispecific, IMA402, as monotherapy and initial data in combination with an immune checkpoint inhibitor at RP2D range expected in 2H 2026 First Phase 1 trial evaluating the combination of Immatics' TCR bispecifics, IMA402 targeting PRAME and IMA401 targeting MAGEA4/8 in sqNSCLC, expected to begin in mid-2026 Cash and cash equivalents as well as other financial assets of $521.5 million1 (€453.6 million) as of March 31, 2026; cash reach projected into 2028 Houston, Texas and Tuebingen, Germany, May 12, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today provided a business update and reported financial results for the quarter ended March 31, 2026...
Metals Creek and Benton Resources Jointly Stake Additional Potential Natural Hydrogen/Helium Project in Newfoundland
Thunder Bay, Ontario--(Newsfile Corp. - May 12, 2026) - Metals Creek Resources Corp. (TSXV: MEK) (OTC Pink: MCREF) (FSE: M1C1) (the "Company" or Metals Creek) and Benton Resources Inc. (TSXV: BEX) (The Companies) are pleased to announce they have jointly acquired through staking an additional 156 units under two licences to cover hydrogen/helium potential in Newfoundland (Smoking Gun Prospect). The Smoking Gun Prospect (See Figure1) was selected after research uncovered highly anomalous helium with values up to 8,900 parts per billion (ppb) (See Table 1) in water collected from an historic drill hole...
Awalé Strengthens Treasury to $17.7 Million with $5.0 Million from Warrant Exercises
Highlights: $17.7 million in cash on hand, supporting exploration across the 100%-owned ground, with Newmont funding JV exploration. $5.0 million raised from the exercise of 6,230,114 common share purchase warrants at $0.80 per share.
NextSource Materials Announces Final Investment Decision for UAE Battery Anode Facility
TORONTO, ON / ACCESS Newswire / May 12, 2026 / NextSource Materials Inc. (TSX:NEXT)(OTCQB:NSRCF) ("NextSource" or the "Company") is pleased to announce that it has approved a Final Investment Decision ("FID") on Phase 1 of its proposed Battery Anode Facility ("BAF") in the Industrial City of Abu Dhabi, UAE, marking a major milestone in the Company's strategy to become a fully integrated, global producer of graphite anode materials. The approval follows the successful completion of Front-End Engineering Design ("FEED"), which confirmed the robust economics and project configuration outlined in the October 2025 BAF Study...
Applied Energetics Selected for Inclusion in AFRL TACTICAL Broad Agency Announcement Topic Area Group
TUCSON, AZ / ACCESS Newswire / May 12, 2026 / Applied Energetics, Inc. (OTCQB:AERG) (AE), a leader in ultrashort pulse directed energy and laser technologies, today announced that it has been selected by the U.S. Air Force Research Laboratory ("AFRL") for inclusion in the TACTICAL Broad Agency Announcement ("BAA") Topic Area Group for "Laser Sources." The AFRL TACTICAL BAA is a five-year initiative managed by the AFRL Directed Energy Directorate focused on advancing next-generation directed energy technologies and innovative laser capabilities for national defense applications...
Elysee Earns $1,930,241 ($0.07 per Share) During the Three Months Ended March 31, 2026
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - Elysee Development Corp. (TSXV: ELC) (FSE: QLDN) (the "Company") is pleased to announce its unaudited financial results for the three months ended March 31, 2026 ("Q1 2026"). All dollar amounts are in Canadian funds.
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders, today announced that the first patient has been dosed in Ascend, its second Phase 3 study evaluating DT120 ODT (lysergide tartrate) for the treatment of major depressive disorder (MDD). The Ascend study will evaluate the...
Vestis Reports Second Quarter 2026 Results and Increases Full Year 2026 Outlook
ATLANTA--(BUSINESS WIRE)--Vestis Corporation (NYSE: VSTS), a leading provider of uniforms and workplace supplies, today announced its financial results for the fiscal second quarter ended April 3, 2026. Second Quarter 2026 Highlights Revenue of $659.4 million Net Income of $2.6 million or $0.02 per diluted share Adjusted Net Income* of $21.8 million or $0.16 per diluted share Adjusted EBITDA* of $74.5 million Cash Flow Provided by Operating Activities of $58.3 million, Free Cash Flow* of $45.6...